By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel agrees that the 30%+ returns of VEA and IXUS in 2025 were driven by transient factors like USD weakness and mean-reversion, not structural improvements. They are essentially global beta plays, not diversifiers, and their correlation can break down under certain scenarios. The decision between the two hinges on emerging market conviction and the trade-off between cost and exposure to emerging markets, particularly Taiwan Semiconductor.
Risk: The 'China-dependency' factor and potential USD regime shift are the biggest risks flagged.
Opportunity: None explicitly stated.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
The Vanguard FTSE Developed Markets ETF offers a lower expense ratio than the iShares Core MSCI Total International Stock ETF.
The iShares Core MSCI Total International Stock ETF provides exposure to emerging markets which are excluded from the Vanguard FTSE Developed Markets ETF portfolio.
The Vanguard FTSE Developed Markets ETF has delivered higher total returns over the last five years despite having a lower trailing dividend yield.
The Vanguard FTSE Developed Markets ETF (NYSEMKT:VEA) offers a lower-cost path to developed economies, while the iShares Core MSCI Total International Stock ETF (NASDAQ:IXUS) provides broader global diversification including emerging markets.
Both funds serve as core international holdings for U.S.-based investors looking to diversify beyond domestic stocks. By capturing thousands of companies outside the U.S., these ETFs help mitigate the risks associated with a single-country portfolio while offering exposure to different currency movements and economic cycles. While they share overlapping positions in global giants, their geographic scopes differ significantly, impacting their risk profiles and long-term growth potential.
| Metric | IXUS | VEA | |---|---|---| | Issuer | iShares | Vanguard | | Expense ratio | 0.07% | 0.03% | | 1-yr return (as of June 1, 2026) | 33.20% | 33.40% | | Dividend yield | 2.80% | 2.60% | | Beta | 0.77 | 0.83 | | AUM | $58.7 billion | $304.3 billion |
Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
The Vanguard FTSE Developed Markets ETF is the more affordable option, charging less than half the fee of the iShares fund. However, the iShares Core MSCI Total International Stock ETF currently provides a higher payout for income-focused investors, with a yield gap of 0.20 percentage points.
| Metric | IXUS | VEA | |---|---|---| | Max drawdown (5 yr) | (30.10%) | (29.70%) | | Growth of $1,000 over 5 years (total return) | $1,502 | $1,593 |
The Vanguard FTSE Developed Markets ETF (VEA) targets 3,873 stocks across developed economies in Canada, Europe, and the Pacific region. Sector exposure includes financial services at 23%, industrials at 19%, and technology at 14%. Its largest positions include Samsung Electronics (KS:005930) at 2.26%, ASML (AMS:ASML.AS) at 1.78%, and SK Hynix (KS:000660) at 1.54%. Launched in 2007, the Vanguard fund has a trailing-12-month dividend of $1.88 per share.
The iShares Core MSCI Total International Stock ETF (IXUS) tracks a broader index of 4,160 stocks that includes emerging markets alongside developed ones. Key sectors include financial services at 22%, technology at 18%, and industrials at 16%. Top holdings include Taiwan Semiconductor Manufacturing (TW:2330) at 4.24%, Samsung Electronics (KS:005930) at 2.25%, and SK Hynix (KS:000660) at 1.96%. Launched in 2012, IXUS paid $2.74 per share over the trailing 12 months.
For more guidance on ETF investing, check out the full guide at this link.
After more than a decade of lagging behind U.S. markets, international stocks staged a remarkable comeback in 2025. Both VEA and IXUS returned more than 30% in the last year, driven by a weakening U.S. dollar, European fiscal stimulus, AI-related growth across Asian markets, and a broad rotation away from historically expensive U.S. valuations. For long-term investors who had neglected international exposure, 2025 was a reminder of why diversification matters.
The question now is whether that momentum continues and how to position for it. VEA focuses exclusively on developed markets including Europe, Japan, and Australia, at one of the lowest fees available for international exposure. IXUS holds even more companies, including markets like India, China, and Brazil alongside the same developed market core, at a modestly higher cost.
Both funds remain attractively valued compared to U.S. equities even after their strong run. VEA is the lower-cost, lower-volatility choice for investors who want developed market exposure without the added complexity of emerging economies. But if you want the broadest possible international diversification in a single fund, choose IXUS.
Before you buy stock in Vanguard FTSE Developed Markets ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vanguard FTSE Developed Markets ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $462,983! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,375,447!
Now, it’s worth noting Stock Advisor’s total average return is 995% — a market-crushing outperformance compared to 212% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of June 3, 2026. *
Sara Appino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Vanguard FTSE Developed Markets ETF. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"The choice between these funds is not about cost or past performance, but about whether you believe emerging markets (IXUS's edge) will outpace developed economies over the next 3-5 years—a bet the article never explicitly asks."
The article frames 2025's 30%+ international rally as a 'comeback' justifying diversification, but conflates short-term momentum with structural revaluation. Yes, VEA and IXUS both returned ~33%, but the article omits critical context: this was driven by USD weakness and mean-reversion after a decade of underperformance—not necessarily improved earnings growth or productivity. VEA's 4 bps fee advantage over IXUS (0.03% vs 0.07%) is real but trivial at scale; the actual decision hinges on emerging market conviction. IXUS's 4.24% TSMC weighting vs VEA's exclusion of China/India/Brazil is the real trade-off, not cost.
If the USD strengthens or Fed rate expectations reset higher in H2 2026, international equities—especially EM-heavy IXUS—could face sharp headwinds. The article's 'attractively valued vs. U.S.' claim lacks P/E or forward earnings support and may simply reflect cyclical positioning rather than fundamental cheapness.
"VEA's lower cost and developed-market focus make it the stronger core holding, but 2025's breakout likely reflects one-off rotations rather than durable outperformance."
VEA's 0.03% expense ratio and $1,593 five-year growth of $1k versus IXUS's 0.07% fee and $1,502 growth highlight its edge in developed markets, yet both ETFs' 33%+ 2025 returns hinged on transient factors like USD weakness and European stimulus. With VEA's 0.83 beta and exclusion of EM volatility, it suits cost-focused investors, but sector tilts toward financials (23%) expose it to rate-sensitive cycles that could reverse quickly.
The article downplays that IXUS's EM inclusion (India, China) could deliver outsized gains if global manufacturing rebounds or if US exceptionalism fades faster than expected, eroding VEA's recent outperformance.
"These ETFs are not distinct asset classes but rather high-beta cyclicals that will likely underperform if the global semiconductor and industrial capital expenditure cycle decelerates."
The 30%+ returns for VEA and IXUS over the past year reflect a classic 'catch-up' trade driven by a weakening USD and mean reversion from U.S. large-cap dominance. While the article frames this as a simple choice between cost and coverage, it ignores the structural risks of the underlying indices. VEA is heavily tilted toward slow-growth European financials and industrials, while IXUS’s 'emerging' exposure is essentially a levered bet on Taiwan Semiconductor and Korean memory cycles. Investors should note that these ETFs are not true diversifiers; they are highly correlated with global beta. If the AI-driven semiconductor cycle cools, both funds will face significant valuation compression regardless of their expense ratios.
The case against this skepticism is that international valuations remain at a multi-decade discount to the S&P 500, offering a meaningful margin of safety if European fiscal stimulus actually gains traction.
"VEA provides a cheaper, lower-risk core international exposure, while IXUS adds EM upside only for investors who can tolerate higher volatility and currency/regulatory risk."
The article frames IXUS vs VEA as a simple cost vs breadth trade-off. Yet it glosses over regime risks: EM exposure can amplify drawdowns when policy or currency moves turn adverse, and a potential USD regime shift can magnify downside for non-US earnings. While 1-year returns look similar, a 5-year view shows VEA outpacing, suggesting a more stable core in a slower-growth world. Fees matter, but not as much as the risk/return profile across cycles; developed-market tilts (VEA) may offer better risk-adjusted outcomes if EM volatility persists. Currency dynamics are a wild card not fully explored.
If the dollar weakens further or EMs ignite a fresh growth upcycle, IXUS could outperform despite higher volatility; the article understates the upside risks embedded in EM exposure.
"The panel conflates mean reversion with diversification; we need to stress-test whether international outperformance persists if USD stabilizes or if correlations re-spike under stress."
Gemini flags the real issue—both funds are essentially global beta plays, not diversifiers. But the panel hasn't addressed what actually matters: correlation breakdowns. If US tech stumbles while European industrials benefit from China stimulus, VEA and IXUS decouple meaningfully. The 33% returns mask that this was a synchronized USD-weakness trade, not proof of structural reallocation. That distinction matters for 2026 positioning.
"Supply-chain linkages prevent the VEA-IXUS decoupling Claude assumes from China stimulus."
Claude's decoupling thesis between VEA and IXUS under China stimulus scenarios misses the tight linkages in global supply chains. European industrial gains would transmit quickly to TSMC and Samsung via component demand, keeping IXUS correlated. Meanwhile VEA remains exposed to the same USD reversal risks flagged earlier, amplified by its financials overweight that could suffer if ECB policy diverges from the Fed.
"The divergence between VEA and IXUS will be driven by whether Chinese stimulus favors domestic consumption (benefiting VEA's European exporters) or industrial capex (benefiting IXUS's tech exposure)."
Grok, your focus on supply chain linkages is correct, but you ignore the fiscal divergence risk. If China’s stimulus focuses on domestic consumption rather than capital expenditure, European luxury and high-end manufacturing in VEA will decouple from the semiconductor-heavy IXUS. The real risk isn't just correlation; it's the 'China-dependency' factor. IXUS is a levered play on Asian manufacturing cycles, whereas VEA is increasingly a proxy for European fiscal policy and credit-sensitive financial stability.
"Durable decoupling between IXUS and VEA is unlikely; regime and liquidity shocks keep global beta in play, so currency hedging and liquidity risk management matter more than expecting a fundamental re-rating."
Claude's decoupling thesis assumes regime shifts that may not happen soon. In practice, cross-border linkages and synchronized policy shocks keep beta intact; even if China stimulus targets consumption, supply chains and earnings expectations are still tied to global growth. For IXUS, currency and EM risk remain amplified; for VEA, ECB-US policy divergence could hit financials. The real edge is hedging currency and liquidity risk, not expecting durable decoupling.
The panel agrees that the 30%+ returns of VEA and IXUS in 2025 were driven by transient factors like USD weakness and mean-reversion, not structural improvements. They are essentially global beta plays, not diversifiers, and their correlation can break down under certain scenarios. The decision between the two hinges on emerging market conviction and the trade-off between cost and exposure to emerging markets, particularly Taiwan Semiconductor.
None explicitly stated.
The 'China-dependency' factor and potential USD regime shift are the biggest risks flagged.